27/06/2019 - Campus Can Ruti, Projects, Research

Financing for a Germans Trias i Pujol project in the third edition of the PERIS call

The Ministry of Health presented the grants for the 2018 and 2019 calls of the Strategic Plan for Innovation in Health (PERIS) on Tuesday. In this year's round the Germans Trias neurologist Natalia Pérez de la Ossa received a grant for the project for pre-hospitalization healthcare for patients with acute stroke. The doctor Daniel Fuster was also awarded a grant for the second edition, which he received at the same ceremony.

20/06/2019 - Campus Can Ruti, Innovation, Institutional, Research

In a brand new format, scientists come together to share and discuss research on the Can Ruti Campus in the First IGTP PI Retreat

Principal investigators from the nine areas of research on the Can Ruti Campus met together to discuss topics of concern in the current research environment. During the day, researchers enjoyed inputs from the IGTP research community and external speakers and were able to take advantage of the many moments available for networking and sharing.

19/06/2019 - Institutional, Research

The IGTP Biobank renews its European certification from the Biorepository Proficiency Testing Program

This is the third round of evaluations the IGTP-HGTP Biobank has undertaken to ensure and certify the quality of its services.  The Biorepository Proficiency Testing Program is a voluntary external evaluation programme, with members from several countries. Once again, the IGTP-HTP Biobank has been awarded the certificate, opting to apply every two years.

17/06/2019 - Research

A new tool that makes it possible to adapt treatment for patients with cardiogenic shock has been discovered

Cardiogenic shock is a possible complication of serious heart attack involving an associated mortality rate of approximately 50% of all cases. The combination of this new tool with existing methods renders precise and patient-specific decision-making possible. The research is being led by Dr. Antoni Bayés at Germans Trias and the Proteomics Unit of the CRG and UPF, under Dr. Eduard Sabidó

07/06/2019 - Innovation, Institutional, Research

Manremyc opens a funding round of 250,000 euros through the Capital Cell platform

Manremyc, a spin-off of the IGTP specialised in the development of a probiotic against tuberculosis, has opened a funding round through Capital Cell, the first on-line investment platform in Europe specialized in biomedicine. The objective of the campaign is to reach 250,000 euros, with a minimum investment requirement per person of only 600 euros. Up to now, the company has secured 35% of the investment, which includes participation from the Reig family, main shareholders in the pharmaceutical company Reig Jofre.

24/05/2019 - Research

The IGTP participates in the debates of the 11th Research Workshop of the ICS: childhood obesity and rare diseases

Experts in paediatric research agree on the need to anticipate and act on obesity from childhood. The importance of early interventions to prevent obesity and excess weight and research into rare diseases have been the main topics of the 11^th Research Workshop of the Catalan Institute of Health (ICS), which took place at the Seminari de Tarragona (Centre Tarraconense).

21/05/2019 - Campus Can Ruti, Research

Surgeons in the Germans Trias Hospital are awarded a Llavor grant to commercialize a new surgical device

The project Mechanical atraumatic microvascular sutures has been awarded a Llavor grant (Seed Grant) by the Catalan Agency for Management of University and Research Grants (AGAUR). This research project is led by Dr M Carmen Higueras Suñé, Head of the Plastic Surgery Service at the Germans Trias Hospital, and the scientist responsible for the commercial development of the device is Dr David Priego, a specialist surgeon in the same department in the hospital.

10/05/2019 - Innovation, Research

Aniling is among the projects selected for this year’s CRAASH Barcelona Programme

Ten international projects have been selected for the second edition of CRAASH Barcelona and Aniling is one of them.  CRAASH is the business acceleration programme organized by Biocat and CIMIT (Boston). Aniling is a spin-off company of the IGTP, which has developed a method for analysing the genome and epigenome of a patient simultaneously, an advance in personalized medicine for both research and clinical settings.

26/04/2019 - Projects, Research

The IGTP is a partner in an international project to improve personalized treatments for childhood cancer using artificial intelligence tools

This year the Childhood Liver Oncology Group (c-LOG) led by Carolina Armengol was one of 21 prestigious International partners from 11 countries joining in the Individualized Paediatric Cure (iPC) Project.  The project has 15 million euros funding for four years and is led by IBM in Switzerland and Technikon in Austria.

09/04/2019 - Research

Researchers at the IGTP identify new candidate biomarkers for the initial stages of childhood diabetes type 1

The Immunology of Diabetes Group at the IGTP has published its first results for their new research line on diabetes type 1 (T1D) in children, focussed on the mechanisms of the re-establishment of tolerance in children at the start of the disease and the definition of new biomarkers for its remission.